You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 292 Immune checkpoint inhibitor induced overlapping cardiac and neuromuscular toxicities: Highlight of early diagnosis, early initiation of immunosuppressive therapy and multidisciplinary management

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
292 Immune checkpoint inhibitor induced overlapping cardiac and neuromuscular toxicities: Highlight of early diagnosis, early initiation of immunosuppressive therapy and multidisciplinary management

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020219018
Dec 20202604
Jan 2021110018
Feb 202126010
Mar 20212805
Apr 20212003
May 202112018
Jun 20210010
Jul 2021007
Aug 2021006
Sep 2021008
Oct 202126020
Nov 202124017
Dec 20218010
Jan 20221601
Feb 20222005
Mar 2022800
Apr 20223605
May 20223402
Jun 20222401
Jul 20221004
Aug 20222204
Sep 20222606
Oct 20221801
Nov 20222207
Dec 20222802
Jan 20232801
Feb 20231401
Mar 20231801
Apr 2023802
May 20231201
Jun 2023400
Jul 2023601
Aug 20232002
Sep 20231400
Oct 20231404
Nov 20232203
Dec 20233400
Jan 20241200
Feb 20242001
Mar 20242200
Apr 20242202
May 20242201
Jun 20242202
Jul 20241603
Aug 20242003
Sep 20242001
Oct 20242809
Nov 20242402
Dec 20241007
Jan 20253608
Feb 2025201
Mar 2025004
Apr 2025007
May 2025005
Jun 2025004
Total12330268